ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53

Oncogene

Volumn 21, Issue 44, 2002, Pages 6722-6728

  Courtois, Stéphanie ^a   Verhaegh, Gerald ^a,d   North, Sophie ^a,e   Luciani, Maria Gloria ^a,f   Lassus, Patrice ^b   Hibner, Ula ^b   Oren, Moshe ^c   Hainaut, Pierre ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e INSERM   (France)

^f UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cell cycle; N terminal domain; p53; p53 isoforms; N p53

Indexed keywords

ISOPROTEIN; MDM2 PROTEIN, HUMAN; MDM2 PROTEIN, MOUSE; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53; REGULATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; ARTICLE; BREAST TUMOR; CELL CYCLE S PHASE; CHEMISTRY; CODON; DNA DAMAGE; FEMALE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; PHYSIOLOGY; TRANSACTIVATION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; CELL CYCLE; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; GENOTOXICITY; GROWTH INHIBITION; HUMAN CELL; MOLECULAR WEIGHT; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; BREAST NEOPLASMS; CODON; DNA DAMAGE; FEMALE; HUMANS; MICE; NUCLEAR PROTEINS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; S PHASE; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037015397     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205874     Document Type: Article

References (38)

1. Balint EE and Vousden KH. (2001). Br. J. Cancer, 85, 1813-1823.
2. Baptiste N, Friedlander P, Chen X and Prives C. (2002). Oncogene, 21, 9-21.
3. Bargonetti J and Manfredi JJ. (2002). Curr. Opin. Oncol., 14, 86-91.
4. Barraille P, Chinestra P, Bayard F and Faye JC. (1999). Biochem. Biophys. Res. Commun., 257, 84-88.
5. Blankenship C, Naglich JG, Whaley JM, Seizinger B and Kley N. (1999). Oncogene, 18, 1529-1535.
6. Candau R, Scolnick DM, Darpino P, Ying CY, Halazonetis TD and Berger SL. (1997). Oncogene, 15, 807-816.
7. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ. (1993). Nat. Genet., 4, 42-46.
8. Hainaut P and Hollstein M. (2000). Adv. Cancer Res., 77, 81-137.
9. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
10. Kozak M. (1987). J. Mol. Biol., 196, 947-950.
11. Kubbutat MH, Jones SN and Vousden KH. (1997). Nature, 387, 299-303.
12. Kubbutat MH and Vousden KH. (1997). Mol. Cell Biol., 17, 460-468.
13. Legros Y, Lafon C and Soussi T. (1994). Oncogene, 9, 2071-2076.
14. Levrero M, De L V, Costanzo A, Gong J, Wang JY and Melino G. (2000). J. Cell Biol. Sci., 113 (Pt 10), 1661-1670.
15. Liu XL, Band H, Gao Q, Wazer DE, Chu Q and Band V. (1994). Carcinogenesis, 15, 1969-1973.
16. Michael D and Oren M. (2002). Curr. Opin. Genet. Dev., 12, 53-59.
17. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR and Bradley A. (1999). Nature, 398, 708-713.
18. Milner J. (1991). Curr. Opin. Cell Biol., 3, 282-286.
19. Molinari M, Okorokov AL and Milner J. (1996). Oncogene, 13, 2077-2086.
20. Nylander K, Coates PJ and Hall PA. (2000). Int. J. Cancer, 87, 368-372.
21. Okorokov AL and Milner J. (1997). Oncol. Res., 9, 267-273.
22. Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR and Miller FD. (2000). Science, 289, 304-306.
23. Reich NC, Oren M and Levine AJ. (1983). Mol. Cell Biol., 3, 2143-2150.
24. Scharnhorst V, Dekker P, van der Eb AJ and Jochemsen AG. (1999). J. Biol. Chem., 274, 23456-23462.
25. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P and Wagner EF. (1999). Gene Dev., 13, 607-619.
26. Stephen CW, Helminen P and Lane DP. (1995). J. Mol. Biol., 248, 58-78.
27. Strano S, Munarriz E, Rossi M, Cristofanelli B, Shaul Y, Castagnoli L, Levine AJ, Sacchi A, Cesareni G, Oren M and Blandino G. (2000). J. Biol. Chem., 275, 29503-29512.
28. Unger T, Mietz JA, Scheffner M, Yee CL and Howley PM. (1993). Mol. Cell Biol., 13, 5186-5194.
29. Veldhoen N, Metcalfe S and Milner J. (1999). Oncogene, 18, 7026-7033.
30. Verhaegh GW, Richard MJ and Hainaut P. (1997). Mol. Cell Biol., 17, 5699-5706.
31. Wahl GM and Carr AM. (2001). Nat. Cell Biol., 3, E277-E286.
32. Walker KK and Levine AJ. (1996). Proc. Natl. Acad. Sci. USA, 93, 15335-15340.
33. Yang A, Kaghad M, Caput D and McKeon F. (2002). Trends Genet, 18, 90-95.
34. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D and McKeon F. (1998). Mol. Cell, 2, 305-316.
35. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C and McKeon F. (1999). Nature, 398, 714-718.
36. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnett H, Dikkes P, Sharpe A, McKeon F and Caput D. (2000). Nature, 404, 99-103.
37. Yin Y, Luciani MG and Fahraeus R. (2002). Nat. Cell Biol., 4, 462-467.
38. Zhu J, Zhou W, Jiang J and Chen X. (1998). J. Biol. Chem., 273, 13030-13036.